OGIVRI (TRASTUZUMAB-DKST) — FDA Approval BLA761074 (MYLAN GMBH)
OGIVRI (TRASTUZUMAB-DKST) — FDA Approval BLA761074 (MYLAN GMBH) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: OGIVRI; Active ingredients: TRASTUZUMAB-DKST; Application number: BLA761074.
| Brand name | OGIVRI |
|---|---|
| Active ingredients | TRASTUZUMAB-DKST |
| Application number | BLA761074 |
| Sponsor | MYLAN GMBH |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20171201 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →